BLPH logo

Bellerophon Therapeutics (BLPH) Earnings Per Share

Annual EPS

-$2.08
-$0.21-11.23%

December 31, 2022

Summary

Performance

1-Year Change

-11.23%

3-Year Change

+29.49%

5-Year Change

+90.15%

15-Year Change

+90.15%

BLPH EPS Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$0.65
BLPH annual earnings per share is currently -420.54% below its historical high of $0.65

3-Year Low

-$2.08
BLPH annual earnings per share is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
BLPH previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
BLPH next annual earnings announcement has not yet been scheduled

OtherBLPHprofitabilitymetrics:

Annual Revenue

-
BLPH annual revenue value is unknown

Annual Gross Profit

-
BLPH annual gross profit value is unknown

Annual Operating Profit

-$22.38 M
BLPH annual operating income is -$22.38 million

Annual Net Income

-$19.83 M
BLPH annual net profit is -$19.83 million

Quarterly EPS

-$0.16
+$0.26+61.90%

September 30, 2023

Summary

Performance

3-Month Change

0%

1-Year Change

+69.81%

3-Year Change

+69.81%

5-Year Change

+89.33%

BLPH Quarterly EPS Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Analysts Estimate

-$0.42
BLPH quarterly earnings per share is currently -61.90% lower than the consensus analysts' forecast

High & Low

All-time High

$0.27
BLPH quarterly earnings per share is currently -159.26% below its historical high of $0.27

3-Year Low

-$0.59

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
BLPH previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
BLPH next earnings announcement has not yet been scheduled

OtherBLPHprofitabilitymetrics:

Quarterly Revenue

-
BLPH quarterly revenue value is unknown

Quarterly Gross Profit

-
BLPH quarterly gross profit value is unknown

Quarterly Operating Profit

-$2.17 M
BLPH quarterly operating income is -$2.17 million

Quarterly Net Income

-$1.92 M
BLPH quarterly net profit is -$1.92 million

TTM EPS

-$0.84
+$0.37+30.58%

September 30, 2023

Summary

Performance

3-Month Change

0%

1-Year Change

+58%

3-Year Change

+58%

5-Year Change

+58%

BLPH TTM EPS Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Analysts Estimate

-$0.73
BLPH TTM earnings per share is currently +15.07% higher than the consensus analysts' forecast

High & Low

All-time High

-$0.84
BLPH TTM earnings per share is currently at an all-time high

3-Year Low

-$2.08

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
BLPH previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
BLPH next earnings announcement has not yet been scheduled

OtherBLPHprofitabilitymetrics:

Annual Revenue

-
BLPH annual revenue value is unknown

Annual Gross Profit

-
BLPH annual gross profit value is unknown

Annual Operating Profit

-$22.38 M
BLPH annual operating income is -$22.38 million

Annual Net Income

-$19.83 M
BLPH annual net profit is -$19.83 million

EPS Formula

EPS =  
Net Income - Preferred Dividends
Shares Outstanding

Annual EPS

-$2.08
BLPH annual earnings per share is -$2.08

Annual Net Income

-$19.83 M
BLPH annual net profit is -$19.83 million

Shares Outstanding

12.23 M
BLPH shares outstanding is 12.23 million

BLPH EPS Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-11.2%+69.8%+58.0%
3 y3 years+29.5%+69.8%+58.0%
5 y5 years+90.2%+89.3%+58.0%

BLPH EPS Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+11.2%at low-159.3%+268.8%at high+147.6%
5 y5-year+11.2%+52.4%-159.3%+575.0%at high+354.8%
alltimeall time-420.5%+3514.7%-159.3%>+9999.0%at high+8711.4%

Bellerophon Therapeutics EPS History

DateAnnualQuarterlyTTM
Sep 2023
-
-$0.16(-61.9%)
-$0.84(-30.6%)
Jun 2023
-
-$0.42(-255.6%)
-$1.21(-0.8%)
Mar 2023
-
$0.27(-150.9%)
-$1.22(-41.3%)
Dec 2022
-$2.08(+11.2%)
-$0.53(0.0%)
-$2.08(+4.0%)
Sep 2022
-
-$0.53(+23.3%)
-$2.00(+2.0%)
Jun 2022
-
-$0.43(-27.1%)
-$1.96(+3.7%)
Mar 2022
-
-$0.59(+31.1%)
-$1.89(+0.5%)
Dec 2021
-$1.87(-41.0%)
-$0.45(-8.2%)
-$1.88(-17.9%)
Sep 2021
-
-$0.49(+36.1%)
-$2.29(-13.3%)
Jun 2021
-
-$0.36(-37.9%)
-$2.64(-5.4%)
Mar 2021
-
-$0.58(-32.6%)
-$2.79(-15.2%)
Dec 2020
-$3.17(+7.5%)
-$0.86(+2.4%)
-$3.29(-1.2%)
Sep 2020
-
-$0.84(+64.7%)
-$3.33(-2.9%)
Jun 2020
-
-$0.51(-52.8%)
-$3.43(-10.2%)
Mar 2020
-
-$1.08(+20.0%)
-$3.82(+30.8%)
Dec 2019
-$2.95(-554.6%)
-$0.90(-4.3%)
-$2.92(+33.3%)
Sep 2019
-
-$0.94(+4.4%)
-$2.19(-20.4%)
Jun 2019
-
-$0.90(+400.0%)
-$2.75(-43.3%)
Mar 2019
-
-$0.18(+5.9%)
-$4.85(-8.0%)
Dec 2018
$0.65
-$0.17(-88.7%)
-$5.27(-55.0%)
DateAnnualQuarterlyTTM
Sep 2018
-
-$1.50(-50.0%)
-$11.70(-13.3%)
Jun 2018
-
-$3.00(+400.0%)
-$13.50(+5.9%)
Mar 2018
-
-$0.60(-90.9%)
-$12.75(-39.7%)
Dec 2017
-$21.11(-10.9%)
-$6.60(+100.0%)
-$21.15(+5.2%)
Sep 2017
-
-$3.30(+46.7%)
-$20.10(-5.6%)
Jun 2017
-
-$2.25(-75.0%)
-$21.30(-14.5%)
Mar 2017
-
-$9.00(+62.2%)
-$24.90(+3.7%)
Dec 2016
-$23.70(-58.3%)
-$5.55(+23.3%)
-$24.01(-21.9%)
Sep 2016
-
-$4.50(-23.1%)
-$30.76(-21.4%)
Jun 2016
-
-$5.85(-27.9%)
-$39.16(-16.3%)
Mar 2016
-
-$8.11(-34.0%)
-$46.81(-18.9%)
Dec 2015
-$56.85(-24.4%)
-$12.30(-4.7%)
-$57.75(-6.2%)
Sep 2015
-
-$12.90(-4.4%)
-$61.54(-7.6%)
Jun 2015
-
-$13.50(-29.1%)
-$66.63(-8.5%)
Mar 2015
-
-$19.05(+18.4%)
-$72.79(+3.1%)
Dec 2014
-$75.19(+4.3%)
-$16.09(-10.6%)
-$70.61(-4.6%)
Sep 2014
-
-$17.99(-8.5%)
-$74.02(+32.1%)
Jun 2014
-
-$19.66(+16.6%)
-$56.02(+54.1%)
Mar 2014
-
-$16.87(-13.5%)
-$36.36(+86.5%)
Dec 2013
-$72.06(+34.1%)
-$19.50
-$19.50
Dec 2012
-$53.73
-
-

FAQ

  • What is Bellerophon Therapeutics annual earnings per share?
  • What is the all time high annual EPS for Bellerophon Therapeutics?
  • What is Bellerophon Therapeutics annual EPS year-on-year change?
  • What is Bellerophon Therapeutics quarterly earnings per share?
  • What is the all time high quarterly EPS for Bellerophon Therapeutics?
  • What is Bellerophon Therapeutics quarterly EPS year-on-year change?
  • What is Bellerophon Therapeutics TTM earnings per share?
  • What is the all time high TTM EPS for Bellerophon Therapeutics?
  • What is Bellerophon Therapeutics TTM EPS year-on-year change?

What is Bellerophon Therapeutics annual earnings per share?

The current annual EPS of BLPH is -$2.08

What is the all time high annual EPS for Bellerophon Therapeutics?

Bellerophon Therapeutics all-time high annual earnings per share is $0.65

What is Bellerophon Therapeutics annual EPS year-on-year change?

Over the past year, BLPH annual earnings per share has changed by -$0.21 (-11.23%)

What is Bellerophon Therapeutics quarterly earnings per share?

The current quarterly EPS of BLPH is -$0.16

What is the all time high quarterly EPS for Bellerophon Therapeutics?

Bellerophon Therapeutics all-time high quarterly earnings per share is $0.27

What is Bellerophon Therapeutics quarterly EPS year-on-year change?

Over the past year, BLPH quarterly earnings per share has changed by +$0.37 (+69.81%)

What is Bellerophon Therapeutics TTM earnings per share?

The current TTM EPS of BLPH is -$0.84

What is the all time high TTM EPS for Bellerophon Therapeutics?

Bellerophon Therapeutics all-time high TTM earnings per share is -$0.84

What is Bellerophon Therapeutics TTM EPS year-on-year change?

Over the past year, BLPH TTM earnings per share has changed by +$1.16 (+58.00%)